The funding will support feasibility work on the development of a social impact bond focussed on drug repurposing. This is using medicine and science already available for use in one disease to create new treatments for patients who suffer from a different rare disease. Due to small patient populations there is no economic incentive for pharmaceutical companies to pursue this research. The grant will fund budget impact models, financial consultation, project management and other support.
